Shares in Sorrento Therapeutics (SRNE) spiked 10.51% in Tuesday’s trading after the company released positive Phase 1b Study results evaluating safety and MTD (maximum tolerated dose) of epidural resiniferatoxin (RTX) injection to treat intractable cancer pain.A majority of patients reported meaningful pain reduction of 30% or more from baseline, and no dose limiting toxicities were reported.The…
Tesla rival? Bill Gates-backed electric vehicle battery startup comes into limelight
by admin •
Musk sees no immediate boost from 'Battery Day' tech unveil
by admin •
Many analysts and industry officials expected Musk to unveil battery improvements at the widely-anticipated event, extending the automaker’s lead over General Motors , Volkswagen and other rivals. In a tweet ahead of the event scheduled for Tuesday, Musk said: “This affects long-term production, especially Semi, Cybertruck & Roadster, but what we announce will not reach…
Longtime ally to Trump's postal chief was paid by RNC
by admin •
A former executive who worked in the private sector for Postmaster General Louis DeJoy was recently paid by President Donald Trump’s reelection effort, according to a new campaign finance disclosure. Joe Hauck, who was formerly vice president of sales and marketing for DeJoy’s New Breed Logistics, was paid $3,000 by the Republican National Committee in…
Biocept’s PCR Testing Remains a Key Piece of the COVID-19 Puzzle; Analyst Says ‘Buy’
by admin •
As the final quarter of 2020 approaches, so does the 2020/2021 flu season. As a result, the demand for COVID-19 testing is only expected to intensify, with those providing solutions set to be rewarded handsomely, according to Wall Street pros.Biocept (BIOC) is among those fighting the good fight against the deadly virus, offering polymerase chain…
Moderna Reveals Efficacy Criteria For Key Covid-19 Vaccine Trials
by admin •
Moderna (MRNA) has taken the rare step of publishing the clinical protocols for its late-stage Covid-19 vaccine trials. The company also announced that it is planning to produce roughly 20M doses of its vaccine candidate, mRNA-1273, this year.According to the published protocol, Moderna is carrying out a Phase 3, randomized, stratified, observer-blind, placebo-controlled study to evaluate the…
3 Biotech Stocks Poised For Massive Future Growth
by admin •
The biotech sector has received a lot of attention and hype lately because of the COVID-19 pandemic. The outbreak has highlighted the importance of science in advancing the course of humanity. Investors have been taking notice and are making investment choices. There has been a lot of activity in the biotech sector, most especially as…
Westfield’s Owner Is Feeding the Banks Again
by admin •
(Bloomberg Opinion) — Unibail-Rodamco-Westfield has a history of shrugging off crises. A decade ago, Europe’s No. 1 operator of top-tier shopping malls and offices doled out cash to shareholders even as banks collapsed and austerity ruled. The rise of online shopping only pushed it further to keep buying trophies like Westfield. That halo of invincibility…
This Biotech Stock Moves One Step Closer to an Alzheimer’s Drug; Analyst Says ‘Buy’
by admin •
In the biotechnology world, clinical data readouts are make-or-break. Release favorable results, and rewards in the form of sky-high gains could be on tap, but if the data misses the mark, shares could also be catapulted, only in the opposite direction.Cassava Sciences (SAVA) is a prime example of the former. On Monday, the company published…
Read This Before Considering Broadcom Inc. (NASDAQ:AVGO) For Its Upcoming US$3.25 Dividend
by admin •
Broadcom Inc. (NASDAQ:AVGO) is about to trade ex-dividend in the next 4 days. Ex-dividend means that investors that…
Hitachi Abandons $26 Billion Nuclear Power Project in U.K.
by admin •
(Bloomberg) — Hitachi Ltd. exited a long-planned U.K. nuclear power project despite the most generous support package for an atomic station in Britain, a bad omen for future projects.The Japanese company announced Wednesday that it decided to withdraw from the Wylfa power project in Wales, citing a worsening investment environment due to the Covid-19 pandemic.…
Coronavirus update: Trump says vaccine ready within weeks; Pfizer says some patients show side effects
by admin •
President Donald Trump reiterated his belief that a coronavirus vaccine may arrive before Election Day, even as top administration health officials have rebuffed such a timeline.